{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T01:02:58Z","timestamp":1776214978403,"version":"3.50.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ad.2020.11.005","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T11:11:40Z","timestamp":1605265900000},"page":"216-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Melanoma en pacientes receptores de un trasplante de \u00f3rgano s\u00f3lido"],"prefix":"10.1016","volume":"112","author":[{"given":"C.","family":"Gonz\u00e1lez-Cruz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Ferr\u00e1ndiz-Pulido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Garc\u00eda-Patos Briones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2020.11.005_bib0315","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/bjd.15931","article-title":"Epidemiology of keratinocyte carcinomas after organ transplantation","volume":"177","author":"Madeleine","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2020.11.005_bib0320","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s40257-018-0355-8","article-title":"Skin Cancer Following Solid Organ Transplantation: A Review of Risk Factors and Models of Care","volume":"19","author":"Howard","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.ad.2020.11.005_bib0325","first-page":"6","article-title":"Actualizaci\u00f3n en c\u00e1ncer de piel en receptores de un trasplante de \u00f3rgano s\u00f3lido","volume":"9","author":"Ferr\u00e1ndiz-Pulido","year":"2018","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.ad.2020.11.005_bib0330","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1111\/j.1600-6143.2008.02326.x","article-title":"Melanoma in organ transplant recipients: Clinicopathological features and outcome in 100 cases","volume":"8","author":"Matin","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ad.2020.11.005_bib0335","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.hoc.2018.09.005","article-title":"Cutaneous Melanoma-A Review in Detection Staging, and Management","volume":"33","author":"Hartman","year":"2019","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.ad.2020.11.005_bib0340","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/j.1600-6143.2010.03078.x","article-title":"Melanoma in solid organ transplant recipients","volume":"10","author":"Zwald","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ad.2020.11.005_bib0345","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<323::AID-JCP2>3.0.CO;2-#","article-title":"T-cell recognition of melanoma-associated antigens","volume":"182","author":"Castelli","year":"2000","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ad.2020.11.005_bib0350","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1038\/jid.2015.312","article-title":"Melanoma Risk and Survival among Organ Transplant Recipients","volume":"135","author":"Robbins","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2020.11.005_bib0355","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMra022137","article-title":"Skin cancers after organ transplantation","volume":"348","author":"Euvrard","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ad.2020.11.005_bib0360","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1600-6143.2008.02510.x","article-title":"Prognosis of pretransplant melanoma","volume":"9","author":"Colegio","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ad.2020.11.005_bib0365","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.mayocp.2012.04.018","article-title":"Melanoma in immunosuppressed patients","volume":"87","author":"Kubica","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ad.2020.11.005_bib0370","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00007890-199601270-00019","article-title":"Malignant melanoma in organ allograft recipients","volume":"61","author":"Penn","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.ad.2020.11.005_bib0375","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/dth.12276","article-title":"Malignant melanoma in organ transplant recipients: incidence, outcomes, and management strategies: A review of literature","volume":"29","author":"D\u017eambov\u00e1","year":"2016","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ad.2020.11.005_bib0380","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jaad.2008.05.015","article-title":"Outcomes of melanoma in recipients of solid organ transplant","volume":"59","author":"Dapprich","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2020.11.005_bib0385","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1001\/archdermatol.2011.159","article-title":"Malignant melanoma in solid transplant recipients: Collection of database cases and comparison with surveillance, epidemiology, and end results data for outcome analysis","volume":"147","author":"Brewer","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2020.11.005_bib0390","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/DSS.0000000000000602","article-title":"Melanoma Outcomes in Transplant Recipients With Pretransplant Melanoma","volume":"42","author":"Arron","year":"2016","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ad.2020.11.005_bib0395","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/ajt.13593","volume":"16","author":"Zwald","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ad.2020.11.005_bib0400","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2133.2005.07094.x","article-title":"Melanomas in renal transplant recipients","volume":"154","author":"Le Mire","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2020.11.005_bib0405","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/tri.13011","article-title":"Increasing incidence of melanoma after solid organ transplantation: A retrospective epidemiological study","volume":"30","author":"Fattouh","year":"2017","journal-title":"Transpl Int"},{"key":"10.1016\/j.ad.2020.11.005_bib0410","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/jamadermatol.2016.4920","article-title":"Incidence of and Risk Factors for Skin Cancer in Organ Transplant Recipients in the United States","volume":"153","author":"Garrett","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ad.2020.11.005_bib0415","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2133.2006.07567.x","article-title":"Melanomas in renal transplant recipients: The London experience, and invitation to participate in a European study","volume":"156","author":"Brown","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2020.11.005_bib0420","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1158\/1055-9965.EPI-09-0278","article-title":"Cutaneous melanoma is related to immune suppression in kidney transplant recipients","volume":"18","author":"Vajdic","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ad.2020.11.005_bib0425","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ad.2015.12.008","article-title":"Skin Cancer Incidence and Mortality in Spain: A Systematic Review and Meta-Analysis","volume":"107","author":"Tejera-Vaquerizo","year":"2016","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2020.11.005_bib0430","article-title":"Melanoma in a cohort of organ transplant recipients: Experience from a dedicated transplant dermatology clinic in Victoria, Australia","author":"Maor","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2020.11.005_bib0435","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/cncr.21404","article-title":"Increased incidence of melanoma in renal transplantation recipients","volume":"104","author":"Hollenbeak","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ad.2020.11.005_bib0440","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/17401","article-title":"Cyclosporine induces cancer progression by a cell-autonomous mechanism","volume":"397","author":"Hojo","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ad.2020.11.005_bib0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13737-014-0022-4","article-title":"Skin cancer in solid organ transplant recipients: Are mTOR inhibitors a game changer?","volume":"4","author":"Geissler","year":"2015","journal-title":"Transplant Res"},{"key":"10.1016\/j.ad.2020.11.005_bib0450","doi-asserted-by":"crossref","first-page":"g6679","DOI":"10.1136\/bmj.g6679","article-title":"Effect of sirolimus on malignancy and survival after kidney transplantation: Systematic review and meta-analysis of individual patient data","volume":"349","author":"Knoll","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ad.2020.11.005_bib0455","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/TP.0b013e3182247ae2","article-title":"Lower malignancy rates in renal allograft recipients converted to sirolimus-based, calcineurin inhibitor-free immunotherapy: 24-month results from the CONVERT trial","volume":"92","author":"Alber\u00fa","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.ad.2020.11.005_bib0460","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/ajt.13597","article-title":"Cyclosporine A Inhibits the T-bet-Dependent Antitumor Response of CD8(+) T Cells","volume":"16","author":"Rovira","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ad.2020.11.005_bib0465","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1586\/edm.10.25","article-title":"Melanoma in immunosuppressed patients","volume":"5","author":"Brewer","year":"2010","journal-title":"Expert Review of Dermatology"},{"key":"10.1016\/j.ad.2020.11.005_bib0470","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jaad.2015.03.045","article-title":"Cutaneous malignant melanoma in the Swedish organ transplantation cohort: A study of clinicopathological characteristics and mortality","volume":"73","author":"Krynitz","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2020.11.005_bib0475","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/cid\/cit940","article-title":"Voriconazole-associated cutaneous malignancy: aAliterature review on photocarcinogenesis in organ transplant recipients","volume":"58","author":"Williams","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ad.2020.11.005_bib0480","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/annonc\/mdz411","article-title":"Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Michielin","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ad.2020.11.005_bib0485","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jaad.2019.09.072","article-title":"Melanoma incidence, stage, and survival after solid organ transplant: A population-based cohort study in Ontario, Canada","volume":"83","author":"Park","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2020.11.005_bib0490","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2340\/00015555-2568","article-title":"Clinical Genetic and Innate Immunity Characteristics of Melanoma in Organ Transplant Recipients","volume":"97","author":"Brocard","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ad.2020.11.005_bib0495","first-page":"739","article-title":"Primary mucosal melanomas: A comprehensive review","volume":"5","author":"Mihajlovic","year":"2012","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.ad.2020.11.005_bib0500","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ad.2017.05.012","article-title":"Novel Additions to the AJCC's New Staging Systems for Skin Cancer","volume":"108","author":"Ca\u00f1ueto","year":"2017","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2020.11.005_bib0505","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2133.2005.07087.x","article-title":"Reduction of immunosuppression for transplant-associated skin cancer: Expert consensus survey","volume":"154","author":"Otley","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2020.11.005_bib0510","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.jdcr.2015.09.020","article-title":"Combined dabrafenib and trametinib therapy in metastatic melanoma and organ transplantation: Case report and review of the literature","volume":"1","author":"Garrett","year":"2015","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.ad.2020.11.005_bib0515","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1200\/JCO.20.00198","article-title":"Systemic Therapy for Melanoma: ASCO Guideline","volume":"38","author":"Seth","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ad.2020.11.005_bib0520","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s40425-019-0585-1","article-title":"Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: An institutional experience and a systematic review of the literature","volume":"7","author":"Abdel-Wahab","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ad.2020.11.005_bib0525","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1001\/jamadermatol.2015.2910","article-title":"BRAF Inhibition in a Lung Transplant Recipient With Metastatic Melanoma","volume":"152","author":"Afshar","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ad.2020.11.005_bib0530","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1684\/ejd.2010.0843","article-title":"BRAF mutations in melanocytic tumors (nevi and melanomas) from organ transplant recipients","volume":"20","author":"Kanitakis","year":"2010","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.ad.2020.11.005_bib0535","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ad.2020.11.005_bib0540","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1053\/j.ackd.2016.08.002","article-title":"The Bad and the Good News on Cancer Immunotherapy: Implications for Organ Transplant Recipients","volume":"23","author":"Maggiore","year":"2016","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.ad.2020.11.005_bib0545","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/ajt.13711","article-title":"Checkpoint Inhibitors in Kidney Transplant Recipients and the Potential Risk of Rejection","volume":"16","author":"Alhamad","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ad.2020.11.005_bib0550","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1016\/j.transproceed.2016.07.019","article-title":"Renal Allograft Failure After Ipilimumab Therapy for Metastatic Melanoma: A Case Report and Review of the Literature","volume":"48","author":"Jose","year":"2016","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ad.2020.11.005_bib0555","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1200\/JCO.2013.49.2314","article-title":"Successful administration of ipilimumab to two kidney transplantation patients with metastatic melanoma","volume":"32","author":"Lipson","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ad.2020.11.005_bib0560","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40425-015-0066-0","article-title":"Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation","volume":"3","author":"Morales","year":"2015","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ad.2020.11.005_bib0565","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2217\/mmt.15.27","article-title":"Report of ipilimumab in a heart transplant patient with metastatic melanoma on tacrolimus","volume":"2","author":"Qin","year":"2015","journal-title":"Melanoma Manag"},{"key":"10.1016\/j.ad.2020.11.005_bib0570","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/CJI.0000000000000077","article-title":"Administration of ipilimumab to a liver transplant recipient with unresectable metastatic melanoma","volume":"38","author":"Ranganath","year":"2015","journal-title":"J Immunother"},{"key":"10.1016\/j.ad.2020.11.005_bib0575","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/annonc\/mdw130","article-title":"Acute renal allograft rejection after immune checkpoint inhibitor therapy for metastatic melanoma","volume":"27","author":"Spain","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ad.2020.11.005_bib0580","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1056\/NEJMc1614298","article-title":"Preserved Renal-Allograft Function and the PD-1 Pathway Inhibitor Nivolumab","volume":"376","author":"Barnett","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ad.2020.11.005_bib0585","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1111\/ajt.13786","article-title":"Use of the PD-1 Pathway Inhibitor Nivolumab in a Renal Transplant Patient With Malignancy","volume":"16","author":"Boils","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ad.2020.11.005_bib0590","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMc1509268","article-title":"Tumor Regression and Allograft Rejection after Administration of Anti-PD-1","volume":"374","author":"Lipson","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ad.2020.11.005_bib0595","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s40425-016-0171-8","article-title":"Antitumor activity of nivolumab on hemodialysis after renal allograft rejection","volume":"4","author":"Ong","year":"2016","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ad.2020.11.005_bib0600","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejca.2016.07.026","article-title":"Checkpoint inhibitors in chronic kidney failure and an organ transplant recipient","volume":"67","author":"Herz","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ad.2020.11.005_bib0605","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/CMR.0000000000000410","article-title":"Immune checkpoint inhibitor therapy in a liver transplant recipient with a rare subtype of melanoma: A case report and literature review","volume":"28","author":"Kuo","year":"2018","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ad.2020.11.005_bib0610","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13256-017-1229-z","article-title":"Pembrolizumab for metastatic melanoma in a renal allograft recipient with subsequent graft rejection and treatment response failure: A case report","volume":"11","author":"Kwatra","year":"2017","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.ad.2020.11.005_bib0615","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s40425-019-0653-6","article-title":"Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment","volume":"7","author":"Hurkmans","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ad.2020.11.005_bib0620","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/CJI.0000000000000319","article-title":"Successful Treatment of In-Transit Metastatic Melanoma in a Renal Transplant Patient With Combination T-VEC\/Imiquimod Immunotherapy","volume":"43","author":"Sunshine","year":"2020","journal-title":"J Immunother"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731020304750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731020304750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:11:55Z","timestamp":1757553115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731020304750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0001731020304750"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2020.11.005","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melanoma en pacientes receptores de un trasplante de \u00f3rgano s\u00f3lido","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2020.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 AEDV. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}